Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to $8.6 million.

  • Sanara MedTech's Shares Outstanding (Weighted Average) rose 151.79% to $8.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.6 million, marking a year-over-year increase of 151.79%. This contributed to the annual value of $8.5 million for FY2024, which is 247.95% up from last year.
  • Latest data reveals that Sanara MedTech reported Shares Outstanding (Weighted Average) of $8.6 million as of Q3 2025, which was up 151.79% from $8.6 million recorded in Q2 2025.
  • Sanara MedTech's Shares Outstanding (Weighted Average)'s 5-year high stood at $8.6 million during Q3 2025, with a 5-year trough of $6.8 million in Q1 2021.
  • Over the past 5 years, Sanara MedTech's median Shares Outstanding (Weighted Average) value was $8.2 million (recorded in 2023), while the average stood at $8.1 million.
  • In the last 5 years, Sanara MedTech's Shares Outstanding (Weighted Average) soared by 4344.97% in 2021 and then surged by 151.79% in 2025.
  • Sanara MedTech's Shares Outstanding (Weighted Average) (Quarter) stood at $7.3 million in 2021, then rose by 7.7% to $7.9 million in 2022, then rose by 4.71% to $8.3 million in 2023, then grew by 2.48% to $8.5 million in 2024, then rose by 1.91% to $8.6 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $8.6 million for Q3 2025, versus $8.6 million for Q2 2025 and $8.6 million for Q1 2025.